279 related articles for article (PubMed ID: 22692724)
1. Changes on brief cognitive instruments over time in Parkinson's disease.
Lessig S; Nie D; Xu R; Corey-Bloom J
Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
[TBL] [Abstract][Full Text] [Related]
4. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
[TBL] [Abstract][Full Text] [Related]
5. The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
Dalrymple-Alford JC; MacAskill MR; Nakas CT; Livingston L; Graham C; Crucian GP; Melzer TR; Kirwan J; Keenan R; Wells S; Porter RJ; Watts R; Anderson TJ
Neurology; 2010 Nov; 75(19):1717-25. PubMed ID: 21060094
[TBL] [Abstract][Full Text] [Related]
6. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.
Videnovic A; Bernard B; Fan W; Jaglin J; Leurgans S; Shannon KM
Mov Disord; 2010 Feb; 25(3):401-4. PubMed ID: 20108371
[TBL] [Abstract][Full Text] [Related]
7. [Study on the status of cognition among Parkinson's disease patients in Xi'an.].
Wang RL; Qu QM; Cao HM; Zhe X; Qiao J; Guo F
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):329-32. PubMed ID: 20510065
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
[TBL] [Abstract][Full Text] [Related]
9. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
[TBL] [Abstract][Full Text] [Related]
10. Cognitive decline in early Parkinson's disease.
Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
[TBL] [Abstract][Full Text] [Related]
11. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores.
Damian AM; Jacobson SA; Hentz JG; Belden CM; Shill HA; Sabbagh MN; Caviness JN; Adler CH
Dement Geriatr Cogn Disord; 2011; 31(2):126-31. PubMed ID: 21282950
[TBL] [Abstract][Full Text] [Related]
12. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
Int J Geriatr Psychiatry; 2003 Nov; 18(11):1043-9. PubMed ID: 14618557
[TBL] [Abstract][Full Text] [Related]
15. Mini-Mental State Examination versus Montreal Cognitive Assessment: rapid assessment tools for cognitive and functional outcome after aneurysmal subarachnoid hemorrhage.
Schweizer TA; Al-Khindi T; Macdonald RL
J Neurol Sci; 2012 May; 316(1-2):137-40. PubMed ID: 22280947
[TBL] [Abstract][Full Text] [Related]
16. Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).
Sánchez-Ferro Á; Benito-León J; Louis ED; Mitchell AJ; Molina-Arjona JA; Trincado R; Villarejo A; Bermejo-Pareja F
Mov Disord; 2013 Feb; 28(2):161-8. PubMed ID: 23239285
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
18. Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.
Luo XG; Feng Y; Liu R; Yu HM; Wang L; Wu Z; Ren Y; He ZY
Dement Geriatr Cogn Disord; 2010; 30(1):64-70. PubMed ID: 20689285
[TBL] [Abstract][Full Text] [Related]
19. A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease.
Chung EJ; Seok K; Kim SJ
Clin Neurol Neurosurg; 2015 Mar; 130():98-100. PubMed ID: 25596487
[TBL] [Abstract][Full Text] [Related]
20. MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.
Biundo R; Weis L; Bostantjopoulou S; Stefanova E; Falup-Pecurariu C; Kramberger MG; Geurtsen GJ; Antonini A; Weintraub D; Aarsland D
J Neural Transm (Vienna); 2016 Apr; 123(4):431-8. PubMed ID: 26852137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
